Table 107.10Overall 5-year Survival and Bladder Preservation: Modern Series (1997–1998)

SeriesNTreatment Survival (%)CR (%)Tumor-free Bladders (%)
RTOG 199348RT + C64‡6673
RTOG 1998175A123RT + C + MCV496678
MGH 1997170A106RT + C + MCV527082
Paris 1997136A120RT + C/5FU6377
Erlangen155A205RT + C*538079

Cisplatin or carboplatin.

For cisplatin, CR was 85% vs 70% for carboplatin.

At 3 years.

From: Chapter 107, Bladder Cancer

Cover of Holland-Frei Cancer Medicine
Holland-Frei Cancer Medicine. 5th edition.
Bast RC Jr, Kufe DW, Pollock RE, et al., editors.
Hamilton (ON): BC Decker; 2000.
© 2000, BC Decker Inc.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.